Literature DB >> 2713790

Identification of the heat-labile hemolysin of Actinobacillus pleuropneumoniae serotype 1.

J Devenish1, S Rosendal.   

Abstract

The heat-labile hemolysin of Actinobacillus pleuropneumoniae serotype 1 strain CM-5 was partially purified using ammonium sulfate precipitation and gel permeation chromatography. This partially purified material was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted onto nylon filters. The filters were treated with convalescent pig serum and subsequently with CM-5 culture supernatant containing active hemolysin. A 104 kd peptide was identified as the hemolysin because it bound antibodies in convalescent pig serum which cross-linked active hemolysin. The same 104 kd protein when injected into a rabbit produced neutralizing antibodies to the CM-5 hemolysin in culture supernatant.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713790      PMCID: PMC1255556     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  12 in total

1.  Production of RNA-dependent haemolysin by Haemophilus pleuropneumoniae.

Authors:  P G Martin; P Lachance; D F Niven
Journal:  Can J Microbiol       Date:  1985-05       Impact factor: 2.419

Review 2.  Haemophilus pleuropneumoniae infection in swine: a review.

Authors:  T N Sebunya; J R Saunders
Journal:  J Am Vet Med Assoc       Date:  1983-06-15       Impact factor: 1.936

3.  Specific detection of inactive enzyme protein after polyacrylamide gel electrophoresis by a new enzyme-immunoassay method using unspecific antiserum and partially purified active enzyme: application to rat liver phosphodiesterase I.

Authors:  H G Muilerman; H G ter Hart; W Van Dijk
Journal:  Anal Biochem       Date:  1982-02       Impact factor: 3.365

4.  Growth and hemolysin production by Haemophilus pleuropneumoniae cultivated in a chemically defined medium.

Authors:  J R Maudsley; S Kadis
Journal:  Can J Microbiol       Date:  1986-10       Impact factor: 2.419

5.  Acute inflammatory effects of intratracheally instilled Escherichia coli endotoxin and sonicated suspension of Haemophilus pleuropneumoniae in swine.

Authors:  A D Liggett; L R Harrison; R L Farrell
Journal:  Can J Vet Res       Date:  1986-10       Impact factor: 1.310

6.  Role of haemophilus pleuropneumoniae lipopolysaccharide endotoxin in the pathogenesis of porcine Haemophilus pleuropneumonia.

Authors:  F A Udeze; K S Latimer; S Kadis
Journal:  Am J Vet Res       Date:  1987-05       Impact factor: 1.156

7.  Isolation, purification, and partial characterization of a lipopolysaccharide from Haemophilus pleuropneumoniae.

Authors:  J R Maudsley; S Kadis; W R Mayberry
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae.

Authors:  S Rosendal; J Devenish; J I MacInnes; J H Lumsden; S Watson; H Xun
Journal:  Am J Vet Res       Date:  1988-07       Impact factor: 1.156

9.  Immune responses to the lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs.

Authors:  B W Fenwick; B I Osburn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Antibody-linked polymerase assay on protein blots: a novel method for identifying polymerases following SDS-polyacrylamide gel electrophoresis.

Authors:  J van der Meer; L Dorssers; P Zabel
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  16 in total

1.  Association of the RTX proteins of Actinobacillus pleuropneumoniae with hemolytic, CAMP, and neutrophil-cytotoxic activities.

Authors:  J Devenish; J E Brown; S Rosendal
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Hemolytic activity in the periodontopathogen Porphyromonas gingivalis: kinetics of enzyme release and localization.

Authors:  L Chu; T E Bramanti; J L Ebersole; S C Holt
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Actinobacillus pleuropneumoniae hlyX gene homology with the fnr gene of Escherichia coli.

Authors:  J I MacInnes; J E Kim; C J Lian; G A Soltes
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

4.  Immunoserological comparison of 104-kilodalton proteins associated with hemolysis and cytolysis in Actinobacillus pleuropneumoniae, Actinobacillus suis, Pasteurella haemolytica, and Escherichia coli.

Authors:  J Devenish; S Rosendal; R Johnson; S Hubler
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae.

Authors:  J N Ma; T J Inzana
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

6.  Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae.

Authors:  J Devenish; S Rosendal; J T Bossé
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

7.  Cytolysins of Actinobacillus pleuropneumoniae serotype 9.

Authors:  M A Smits; J Briaire; R Jansen; H E Smith; E M Kamp; A L Gielkens
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Prevalence of seroreactors to the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae in swine herds.

Authors:  J Devenish; S Rosendal; J T Bossé; B N Wilkie; R Johnson
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

9.  Influence of Actinobacillus pleuropneumoniae serotype 2 and its cytolysins on porcine neutrophil chemiluminescence.

Authors:  P Dom; F Haesebrouck; E M Kamp; M A Smits
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies.

Authors:  E M Kamp; J K Popma; J Anakotta; M A Smits
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.